HOME > ARCHIVE
ARCHIVE
- Safety Measures for Cattle-derived Materials Strengthend
April 28, 2003
- Mixing of Insurance-covered, Non-covered Care Difficult in Japan: Prof Ikegami
April 28, 2003
- Pharmaceutical Industry Has Entered a Paradigm Shift: OPSR President
April 28, 2003
- Nat'l Univ Hospitals Have to Report Serious Medical Accidents
April 28, 2003
- REGULATORY NEWS IN BRIEF
April 28, 2003
- ON THE MOVE
April 28, 2003
- DPC System Introduced at 15 Hospitals on April 1: PJ Survey
April 28, 2003
- Drug Makers' Cooperation Sought in Providing Drugs for Physician-led Clinical Trials: Ihoken Meeting
April 28, 2003
- Chuikyo Subcommittee Selects Top Priority Issues
April 28, 2003
- IMSJ Discontinues Providing Info on Sales by Individual Medical Institutions
April 28, 2003
- The 26th General Assembly of the Japan Medical Congress (2)
April 28, 2003
- Novartis' Symmetrel to Be Focused on Original Indications
April 28, 2003
- Clinical Proteome Center Opens in Tokyo Medical University
April 28, 2003
- Teijin Introduces Corporate Governance Guide
April 21, 2003
-
April 21, 2003
- Synix's Doctor's Guide Gains Reputation from Physicians
April 21, 2003
- Tax Breaks Approved for 8 Types of Medical Device: Korosho
April 21, 2003
- Market for CRO Business to Expand to \80 Bil. in 2005
April 21, 2003
- Results of Clinical Trial on Paclitaxel-Eluting Stent Presented: Boston Scientific
April 21, 2003
- BUSINESS NEWS IN BRIEF
April 21, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
